{"id":724726,"date":"2023-01-20T08:05:31","date_gmt":"2023-01-20T13:05:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/"},"modified":"2023-01-20T08:05:31","modified_gmt":"2023-01-20T13:05:31","slug":"bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/","title":{"rendered":"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications"},"content":{"rendered":"<div class=\"mw_release\">\n<ul>\n<li>27 different customers representing\u00a0North America\u00a0and\u00a0Europe<\/li>\n<li>30 oral presentations across four consecutive days<\/li>\n<li>34 scientific posters will be featured in a virtual exhibition hall<\/li>\n<li>Topics span the application of optical genome mapping (OGM) in genetic disease, cancer research and cell bioprocessing<\/li>\n<\/ul>\n<p>SAN DIEGO, Jan.  20, 2023  (GLOBE NEWSWIRE) &#8212; Bionano Genomics, Inc.\u00a0(Nasdaq: BNGO) today announced its Symposium 2023 lineup of 30 oral presentations delivered from 27 different customers worldwide featuring the utility of optical genome mapping (OGM) across a wide range of applications for genetic disease and cancer research and for cell bioprocessing. The symposium will take place virtually from\u00a0January 23 to 26, 2023. During these four days, customers will showcase their latest research findings using OGM. Each day will feature oral customer presentations, a live panel with Q&amp;A and a wide range of scientific posters within the virtual exhibition hall.<\/p>\n<p>\u201cWe believe Symposium is the quintessential event for the OGM community to come together and share the progress they are making in genetic disease and cancer research using OGM alongside other genome analysis tools,\u201d said\u00a0Erik Holmlin, PhD, president and chief executive officer of\u00a0Bionano Genomics. \u201cWhat impresses me most about the Symposium lineup for 2023 is the sheer breadth of topics, ranging from neural tube defects, prenatal testing, homologous recombination deficiency (HRD) analysis in breast cancer to drug development with cell bioprocessing QC.\u00a0Symposium is an opportunity for anyone interested or currently working with OGM to form connections within the community and see the potential impact of looking at the genome in a different way. I am looking forward to seeing our global customers showcase their accomplishments with OGM at Symposium.\u201d<\/p>\n<p>\u201cOur 2022 Symposium was a fantastic event where OGM users showcased their data. Since then, we have made significant improvements in OGM workflow and data analysis which have allowed our customers to advance their clinical and translational research. We have seen the implementation of our Saphyr\u00ae system across a broad range of clinical research applications, including consolidating traditional cytogenetics workflows to OGM and demonstrating OGM\u2019s utility in combination with NGS,\u201d said\u00a0Alka Chaubey, PhD, FACMG, chief medical officer at Bionano. \u201cSymposium attendees have an opportunity to learn from their peers and we will continue to provide our customers with the training, education and services to support our goal of greater adoption of OGM.\u201d<\/p>\n<p>Each session of Symposium will start at\u00a07:00 am PST\u00a0and will last approximately 3 hours. After the scientific presentations, the speakers will join for a live panel discussion and Q&amp;A moderated by\u00a0Dr. Chaubey. In addition, each day will feature a scientific poster exhibit. Below is the list of customer presentations per day and application area.<\/p>\n<p>January 23: Oncology-heme malignancies<\/p>\n<table align=\"center\" style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Speaker <\/strong>\n          <\/td>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Institution <\/strong>\n          <\/td>\n<td style=\"max-width:60%;width:60%;min-width:60%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Title <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Adrian Dubuc<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Brigham and<br \/>Women&#8217;s Hospital<br \/>and Harvard<br \/>Medical School<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">From\u00a0Masked\u00a0Complexity\u00a0to\u00a0Chromosomal\u00a0Mimicry:\u200b Using Optical Genome Mapping to Characterize Cancer Genomes<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Veronika Butin-Israeli<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Shaarei Zedek<br \/>Medical Center<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Role of Nuclear Architecture in Chromosomal Instability of Myeloid Malignancies. New Insights with OGM<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Victoria Marcu<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Chaim Sheba<br \/>Medical Center<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Validation of\u00a0OGM\u00a0for\u00a0Cytogenomic\u00a0Testing in\u00a0Hemato-oncology \u2013 Sheba Experience\u200b<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Estelle Balducci<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Necker Children\u2019s<br \/>Hospital<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Optical Genome Mapping Refines Cytogenetic\u00a0Diagnostics, Prognostic Stratification and\u00a0Provides New Molecular Insights in Adult\u00a0MDS\/AML Patients<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Ravi Kolhe<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Augusta University<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Going beyond Karyotyping and FISH: Impact of Optical Genome Mapping (OGM) with Additional Clinically Relevant Information in 75 Hematological Malignancy Cases<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Blanca Espinet<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Hospital del Mar<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">The Spanish-OGM Heme Working Group<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Adam Smith<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">University Health Network,<br \/>University of Toronto<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">International Working Group Recommendations\u00a0for the Clinical Implementation of Optical\u00a0Genome Mapping in Hematologic Malignancies<\/td>\n<\/tr>\n<\/table>\n<p>\n        <br \/>January 24: Oncology- Heme malignancies and solid tumors<\/p>\n<table align=\"center\" style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Speaker<\/strong>\n          <\/td>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Institution<\/strong>\n          <\/td>\n<td style=\"max-width:60%;width:60%;min-width:60%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Title <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Ravi Kolhe<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Augusta<br \/>University<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Complementarity of Optical Genome Mapping and Next Generation Sequencing Panel (523 genes) for the Comprehensive Evaluation of Myeloid Neoplasms<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Rashmi Kanagal<br \/>Shamanna<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">The University of<br \/>Texas MD<br \/>Anderson<br \/>Cancer Center<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Exploratory Role of OGM Applications in Immunotherapies<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Marcin Imieli\u0144ski<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">New York<br \/>Genome Center<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Resolving Complex Structural\u00a0Variation with OGM and Genome\u00a0Graphs<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Juan D\u00edaz-Mart\u00edn<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Instituto de<br \/>Biomedicina de<br \/>Sevilla, IBiS-HUVR<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Complex Rearrangement Patterns in Ewing Sarcoma Associated\u00a0with Poor Clinical Outcome<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Daniel Ackerman<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">University of<br \/>Pennsylvania<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Neuroendocrine Tumor Liver Metastases\u200b: Understanding Metastatic Progression by Identifying Genetic Drivers of Disease<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Sandra Vanhuele<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Institut Curie,<br \/>Inserm U830<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Features of Homologous Recombination Deficiency (HRD)\u00a0\u200bin Triple Negative Breast Cancers (TNBC) using Optical Genome Mapping<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Jef Baelen<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">KU Leuven<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Optical Genome Mapping for Comprehensive (Cyto)genetic\u00a0Analysis of Sarcomas in a Diagnostic Setting\u200b<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n        <br \/>January 25: Constitutional Genetic Diseases<\/p>\n<table align=\"center\" style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Speaker<\/strong>\n          <\/td>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Institution<\/strong>\n          <\/td>\n<td style=\"max-width:60%;width:60%;min-width:60%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Title<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Roger Stevenson<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Equanimitas<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Neural Tube Defects<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Brynn Levy<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Columbia<br \/>University<br \/>Medical Center<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Prenatal Clinical Study<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Roger Stevenson<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Equanimitas<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Multisite Optical Genome Mapping Postnatal Study<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Anja Kovanda &amp;<br \/>Dr. Borut Peterlin<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">University<br \/>Medica Center<br \/>Ljubljana<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">FSHD\u00a0Testing\u00a0by\u00a0OGM in\u00a0the\u00a0Clinical\u00a0Setting\u00a0\u2013\u00a0Our\u00a0Experience\u200b<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Avinash<br \/>Dharmadhikari<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Children&#8217;s<br \/>Hospital of Los<br \/>Angeles\/ Keck<br \/>School of<br \/>Medicine of<br \/>University of<br \/>Southern<br \/>California<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Optical Genome Mapping Improves Clinical Interpretation of Constitutional Copy Number Gains<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">B\u00e1rbara Fern\u00e1ndez<br \/>Garoz<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Ni\u00f1o Jes\u00fas<br \/>Hospital<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Next-generation Cytogenetics: Optical Genome Mapping in Peripheral Blood Samples<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Alex Hoischen<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Radboud<br \/>University<br \/>Medical Center<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Optical Genome Mapping: Hidden SVs in Rare Diseases<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Detlef Trost<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Laboratoires<br \/>CERBA<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Optical Genome Mapping as a Diagnostic Tool in Cases of Unresolved Rare Diseases<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Dr. Isabelle<br \/>Schrauwen<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Columbia<br \/>University<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Optical Genome Mapping in Genetically Unsolved Neurodevelopmental\u00a0Disorders<\/td>\n<\/tr>\n<\/table>\n<p>\n        <br \/>January 26: Cell Bioprocessing<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">\n            <strong>Speaker<\/strong>\n          <\/td>\n<td style=\"max-width:20%;width:20%;min-width:20%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">\n            <strong>Institution<\/strong>\n          <\/td>\n<td style=\"max-width:60%;width:60%;min-width:60%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">\n            <strong>Title<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Dr. Alex Hastie<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Bionano<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Utilization of Optical Genome\u00a0Mapping for Cell Quality Control\u00a0in Cell Therapy Applications\u200b<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Dr. Somayeh Tarighat<br \/>&amp; Dr. Andrew McKay<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Genentech, Inc.<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Optical Genome Mapping and Cell\u00a0Product Characterization<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Darisha Jiadani<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Bionano<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Introducing Generation 2 (G2): Saphyr OGM Sample Preparation<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Dr. Andy Pang<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Bionano<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Quality Assessment\u00a0for Cell Bioprocessing<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Dr. Ben Finlay<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Sanford<br \/>Burnham<br \/>Prebys Medical<br \/>Discovery<br \/>Institute<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">OGM Analyses of CAR-NK \u201cLiving Drugs\u201d<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Nahed Darwish<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Synthego<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Evaluation of CRISPR Edits\u00a0Using Bionano\u2019s Optical\u00a0Genomic Mapping Karyotyping<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">Dr. Saumyaa<br \/>Saumyaa<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Genome Editing<br \/>Safety<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Cell QC Using OGM<\/td>\n<\/tr>\n<\/table>\n<p>\n        <br \/>Symposium registration is open to all and there is no charge for attending this event. Register today at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F31-ETO1jlG8zGFesSN-j0xvf_dabPBiGyX8pLOWiZQAOBP9AQBnF9_63TmTpKm0p4OE2O-z64bbW7P2TTCx7MgXftcNANHRAs__Yu90-aqXPfborChrCGHGvw0I6vwxaARtHhkB3iuDnwtliIwMIbih9UOaMJTj5yh6qX5hkzc=\" rel=\"nofollow noopener\" target=\"_blank\">Bionano Symposium 2023 (labroots.com)<\/a><\/p>\n<p>\n        <strong>About Bionano Genomics<\/strong>\n      <\/p>\n<p align=\"justify\">Bionano Genomics\u00a0is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company\u2019s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. Through its\u00a0Lineagen, Inc.\u00a0d\/b\/a\u00a0Bionano Laboratories\u00a0business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, the Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f5fZjjasJM5fhnxD3en-vLAhfkJHpd9zEaN0zYEV1aLkan6xL5fqMSdn6xbU8a8JlAYUUa6oLBIJF2slRzbsz94TiSmAQr8xFN-8-3uyDXxmO0QSK9wxdciGNehg4CAWjPsRlo0Dnp-2yJLy3EItCz5ySMryO3Hz4kC4aax2BlB1u0GbNXPq-r-jhwvZGrv6luY9ltCblzS4AS2XN-LbQFDszpupAzkWjYk6SNKltjNKuAIIzIUZ3smljZVh5wqsrkLFR8xgiQR2T5UU3RX-2Q==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.bionanogenomics.com<\/u><\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f5fZjjasJM5fhnxD3en-vLpCtZ64tSHdHx58EQylsIJ6-RQ1WaylvEmCPs2H1nmUPU1MW-ugvRAO39bG6Ln03G_mMzRdC8W04Ob4t9BhrcyZN23VnRRhaZ2U4OWvgsC-LX77I1xALMdro31OdugB00cb_KDkEBQCxZuTfZg8irsA1z_MzjqRGpyVd7EHAyvH8PQrWv2wONmQc8y2PhXx6yh1YJB58bxcloR7EPfDmcM4vtefiUZ4kEWUFkn3s2zysm6zG-oe13xzYlBwF5zQ3uIGQovrVnwVInu5bKTZfBc=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.bionanolaboratories.com<\/u><\/a>\u00a0or\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f5fZjjasJM5fhnxD3en-vGzdhCOt6mGzo__HtUZOhaK4NgeMIHq4pmD8NS975Qne6hb9THupr_HJFAmrDgQjUqWwVrcCJ7CXj3-7AlKE0j5H-h1NLnoeJNXkufpWCNMKWqfy1P7LOhQg5mJwmKHuxeyObfM0NUVJ5zdvmy9GDubtBoEqEw5ehUl0BUSUKdRMt47lldeMNkyM5S8b6VvGf21KGyyArdWvntzyxZRQgzDs2H7awwfizOc2RU-u5_xknyl_Lat3zlkrqK-zAx_T2w==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.biodiscovery.com<\/u><\/a><\/p>\n<p>Bionano\u2019s OGM products are for research use only and not for use in diagnostic procedures.<\/p>\n<p>\n        <strong>Forward-Looking Statements of Bionano Genomics<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as \u201cbelieve,\u201d \u201cpotential,\u201d and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify these forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, OGM\u2019s utility for research in areas including genetic diseases and cancers, OGM\u2019s utility in cell bioprocessing QC, and the growth and adoption of OGM. Each of these forward-looking statements involves risks and uncertainties. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of geopolitical and macroeconomic developments, such as the ongoing Ukraine-Russian conflict, and related sanctions, and the COVID-19 pandemic, on our business and the global economy; general market conditions; changes in the competitive landscape and the introduction of competitive technologies or improvements to existing technologies; failure of OGM to prove useful for research in areas including genetic diseases and cancers; failure of OGM to prove useful for cell bioprocessing QC; failure of laboratories to adopt OGM; the ability of our OGM solutions to offer the anticipated benefits for and contributions to the areas reported in the presentations given and posters made available at Symposium 2023; future study results contradicting the results reported in the presentations given and posters made available at Symposium 2023; changes in our strategic and commercial plans; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; the ability of medical and research institutions to obtain funding to support adoption or continued use of our technologies; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2021 and in other filings subsequently made by us with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management\u2019s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>Company Contact:<\/strong><br \/>\n        <br \/>Erik Holmlin, CEO<br \/>Bionano Genomics, Inc.<br \/>+1 (858) 888-7610<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uuA5ffbgqQTr0dsbcg27v-WpODzLOA_PjTkrKM7YjUTkOQiqffIOUJIbQiVAeYqAjNYDabhuJu-DxtFqFlvum3vb2jAYD7gnO2hPV8ksFMZGrjvjUKCywz9hpvaKsC00\" rel=\"nofollow noopener\" target=\"_blank\">eholmlin@bionanogenomics.com<\/a><\/p>\n<p>\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>Amy Conrad<br \/>Juniper Point<br \/>+1 (858) 366-3243<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DgpidS9n3Pmyk5H15t6TegFMCMeas_dLEmUxSWJYqfVI1sl2HTN3DYjo4fYSyEVnC_6CEIKqs9f9yfa9rqzhKV1Vid-YI-hPBvuej29hOAc=\" rel=\"nofollow noopener\" target=\"_blank\">amy@juniper-point.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YzAzM2U2YzItZjQyNy00Y2EzLTkwN2ItZGZiMjY5NTBjZDc0LTUwMDA1MjUyMQ==\/tiny\/Bionano-Genomics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>27 different customers representing\u00a0North America\u00a0and\u00a0Europe 30 oral presentations across four consecutive days 34 scientific posters will be featured in a virtual exhibition hall Topics span the application of optical genome mapping (OGM) in genetic disease, cancer research and cell bioprocessing SAN DIEGO, Jan. 20, 2023 (GLOBE NEWSWIRE) &#8212; Bionano Genomics, Inc.\u00a0(Nasdaq: BNGO) today announced its Symposium 2023 lineup of 30 oral presentations delivered from 27 different customers worldwide featuring the utility of optical genome mapping (OGM) across a wide range of applications for genetic disease and cancer research and for cell bioprocessing. The symposium will take place virtually from\u00a0January 23 to 26, 2023. During these four days, customers will showcase their latest research findings using OGM. Each day will feature &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-724726","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"27 different customers representing\u00a0North America\u00a0and\u00a0Europe 30 oral presentations across four consecutive days 34 scientific posters will be featured in a virtual exhibition hall Topics span the application of optical genome mapping (OGM) in genetic disease, cancer research and cell bioprocessing SAN DIEGO, Jan. 20, 2023 (GLOBE NEWSWIRE) &#8212; Bionano Genomics, Inc.\u00a0(Nasdaq: BNGO) today announced its Symposium 2023 lineup of 30 oral presentations delivered from 27 different customers worldwide featuring the utility of optical genome mapping (OGM) across a wide range of applications for genetic disease and cancer research and for cell bioprocessing. The symposium will take place virtually from\u00a0January 23 to 26, 2023. During these four days, customers will showcase their latest research findings using OGM. Each day will feature &hellip; Continue reading &quot;Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-20T13:05:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications\",\"datePublished\":\"2023-01-20T13:05:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/\"},\"wordCount\":1605,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/\",\"name\":\"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==\",\"datePublished\":\"2023-01-20T13:05:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/","og_locale":"en_US","og_type":"article","og_title":"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications - Market Newsdesk","og_description":"27 different customers representing\u00a0North America\u00a0and\u00a0Europe 30 oral presentations across four consecutive days 34 scientific posters will be featured in a virtual exhibition hall Topics span the application of optical genome mapping (OGM) in genetic disease, cancer research and cell bioprocessing SAN DIEGO, Jan. 20, 2023 (GLOBE NEWSWIRE) &#8212; Bionano Genomics, Inc.\u00a0(Nasdaq: BNGO) today announced its Symposium 2023 lineup of 30 oral presentations delivered from 27 different customers worldwide featuring the utility of optical genome mapping (OGM) across a wide range of applications for genetic disease and cancer research and for cell bioprocessing. The symposium will take place virtually from\u00a0January 23 to 26, 2023. During these four days, customers will showcase their latest research findings using OGM. Each day will feature &hellip; Continue reading \"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-20T13:05:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications","datePublished":"2023-01-20T13:05:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/"},"wordCount":1605,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/","name":"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==","datePublished":"2023-01-20T13:05:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzI0OCM1MzY1Mzc3IzUwMDA1MjUyMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-announces-the-final-speaker-lineup-for-symposium-2023-with-30-ogm-presentations-and-live-panel-discussions-across-a-wide-range-of-genetic-disease-and-cancer-research-applications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/724726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=724726"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/724726\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=724726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=724726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=724726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}